Sotagliflozin
LX-4211 is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and 2 (SGLT2), with potential antihyperglycemic activity.
| Catalog Number | T3547 |
| Alternative Name(s) | LX-4211 , LP-802034 |
| Research Area | GPCR/G Protein |
| Molecular Formula | C21H25ClO5S |
| CAS# | 1018899-04-1 |
| Purity | 98.00% |
| SMILES | [C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)SC)O)O)O)c1cc(c(cc1)Cl)Cc1ccc(cc1)OCC |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Sotagliflozin |
| Additional Information | https://www.targetmol.com/datasheet/T3547 |